Sarah J. Schlesinger Innoviva, Inc. (INVA) insider trading activity

Sarah J. Schlesinger is Director of Innoviva, Inc.. Currently has a direct ownership of 130,706 shares of INVA, which is worth approximately $2.51 Million. The most recent transaction as insider was on May 19, 2025, when has been sold 12,077 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K

10.18% 3M change

10.18% 12M change

Total Value Held $2.51 Million

Sarah J. Schlesinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2025	BUY Grant, award, or other acquisition	-	12,077 Added 8.46%	130,706 Common Stock
Jun 17 2024	BUY Grant, award, or other acquisition	-	13,923 Added 10.5%	118,629 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	16,495 Added 13.61%	104,706 Common Stock
Apr 25 2022	BUY Grant, award, or other acquisition	-	12,647 Added 12.54%	88,211 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	-	17,482 Added 18.79%	75,564 Common Stock

Also insider at

ARMP

Armata Pharmaceuticals, Inc. Healthcare

Director

SJS